About

Bridging Regulatory Precision with Enterprise Execution

Founded in 2015, Brighton Ashford, LLC serves at the intersection of life sciences business strategy, strict federal regulation, and hands-on operational leadership. We don’t operate from an ivory tower; we step onto the facility floor to build, validate, and scale high-compliance organizations.

We specialize in guiding ethical pharmaceutical, medical device, and combination product companies through the complex web of FDA compliance, patent prosecution, and civil or criminal litigation support.

Our Leadership Philosophy: Advise, Design, Execute

Many consulting firms hand over a playbook and walk away. At Brighton Ashford, we believe true consultation requires a deep commitment to execution.

We put this philosophy into action when we were engaged as strategic consultants to design the blueprint for a state-of-the-art, dual-compliant (cGMP/ISO) CRO. Recognizing our deep understanding of the vision and strict regulatory demands, our client appointed our leadership directly into the role of President to execute the end-to-end operationalization of the facility.

We took that project from a blank piece of paper to a 10,000 sq. ft. fully validated asset, managing:

• Site and Vendor Negotiations: Leading facility acquisition, layout design, and critical utility setup.

• Rigorous Validation: Overseeing complete licensing and full IQ/OQ/PQ instrument qualification.

• Human Capital Architecture: Structuring corporate workflows, hiring a core 8-member expert staff, and deploying complete GxP training.

• The Digital-First Lab: Eliminating traditional paper bottlenecks by building a 100% paperless Good Documentation Practices (eGDP) environment alongside a custom virtual client-onboarding and secure data-access portal.

Why Partners Trust Us

The modern life sciences landscape demands more than just scientific knowledge—it requires an understanding of corporate flow, security, and the federal legal framework.

With deep experience handling NIH-GMP site requirements for CROs and CDMOs, managing operational flow, and navigating complex intellectual property and litigation challenges, Brighton Ashford acts as a shield and an accelerator for your business. As pharmaceutical manufacturing repatriates to the United States and supply chains require aggressive domestic retesting, we position our clients to capture revenue swiftly and securely.

Whether you are designing a laboratory environment from inception or require a high-stakes assessment of your current GxP operations, we bring the execution-tested leadership you need.